Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 252

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 252
---
 Iris Class A Shares of such holder for redemption not later than 5:00 p.m. Eastern Time on the date that is two Business Days prior to the date of the Special Meeting. As of January 2, 2025, this would have amounted to approximately $11.47 per share (net of all applicable taxes payable from the Trust Account). If a holder of public shares properly exercises his, her or its redemption rights, then such holder will be exchanging his, her or its shares of Iris Class A Common Stock for cash and will no longer own such shares. See the section entitled “ Special Meeting of Iris Stockholders — Redemption Rights and Procedures ” for procedures to be followed if you wish to redeem your shares for cash and not own the ParentCo common stock following consummation of the Business Combination. After the special stockholders meeting held by Iris on December 20, 2024, to vote upon a charter amendment to extend the time to complete a business combination until March 31, 2025 (subject to an additional three month extension at the discretion of the Board), public stockholders elected to redeem 64,453 shares of common stock, resulting in $2,001,033 of funds remaining in the Trust Account (as adjusted for redemptions paid out of the Trust Account in January 2025) and 174,477 shares of Iris Class A Common Stock held by the public stockholders. Impact of the Business Combination on ParentCo’s Public Float The following table summarizes the pro forma equity ownership in ParentCo Common Stock immediately following the Business Combination under three redemption scenarios.

| ​                                 | ​ | ​ | Assuming NoAdditionalRedemptions(1)(2) |   |            |   | ​ | ​ | %Ownership |   |      |   | ​ | ​ | Assumingan additional50%Redemption(1)(3) |   |            |   | ​ | ​ | %Ownership |   |      |   | ​ | ​ | AssumingMaximumRedemptions(1) |   |            |   | ​ | ​ | %Ownership |   |      |   | ​ |
| Iris public stockholders          | ​ | ​ | ​                                      | ​ |    174,477 | ​ | ​ | ​ | ​          | ​ |  0.7 | ​ | ​ | ​ | ​                                        | ​ |     87,238 | ​ | ​ | ​ | ​          | ​ |  0.3 | ​ | ​ | ​ | ​